Arcus Biosciences Inc (NYSE:RCUS)
$ 27.92 +1.47 (+5.56%) Market Cap: 3.51 Bil Enterprise Value: 2.80 Bil PE Ratio: 0 PB Ratio: 6.68 GF Score: 41/100

Arcus Biosciences Inc at Goldman Sachs Healthcare Conference Transcript

Jun 09, 2026 / 02:40PM GMT
Release Date Price: $23.64 (+1.37%)
Terry Rosen
Arcus Biosciences Inc - Chairman of the Board, Chief Executive Officer, Co-Founder

I was giving a commencement address.

Unidentified Participant

All right. Let's kick off our next session with me, Terry.

Welcome.

Thank you. Very exciting times this year.

And before we go to the question, which I have a lot, I'm going to turn it to you guys for opening remarks. Great.

Terry Rosen
Arcus Biosciences Inc - Chairman of the Board, Chief Executive Officer, Co-Founder

So let me just introduce Arkes to those of you out here who might not be as familiar with us. I'll be brief.

The company was founded about 10 years ago. We built ourselves around a very strong R&D capability, particularly discovery.

That's reflected in the type of programs we choose. We focus on programs, particularly with small molecules, where there's been great validation, but perhaps not a great molecule yet. And I think that leads me to Casdatafan, which is clearly our most valuable program right

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot